What question did this study set out to answer?

To review the clinical characteristics, distinct molecular profiles, and treatment strategies for uncommon and rare subtypes of malignant melanoma.

August 21, 2020CancersOpen Access

Uncommon Subtypes of Malignant Melanomas: A Review Based on Clinical and Molecular Perspectives

View Full Paper

Ask AI

Bookmark

To review the clinical characteristics, distinct molecular profiles, and treatment strategies for uncommon and rare subtypes of malignant melanoma.
Synthesized evidence on non-classical cutaneous melanomas lacking standard BRAF V600E/K mutations, as well as mucosal and uveal melanoma variants.
Evaluated distinctive histopathologic entities, such as amelanotic, desmoplastic, and spitzoid melanomas, alongside lesions originating in non-traditional primary sites like the meninges, esophagus, and breast.
Commonly approved targeted therapies and immune checkpoint inhibitors exhibit variable efficacy in non-cutaneous and atypical subtypes due to distinct genetic backgrounds.
A lack of standardized diagnostic criteria and prospective clinical trial data currently limits consensus therapeutic pathways for rare primary melanoma sites.

No takes yet. Share an insight, caveat, or question.

Review highlights clinical and molecular features in rare melanoma subtypes, suggesting the urgent need for tailored therapeutic approaches.

Chacón et al. (2020) studied this question.

View Full Paper

Ask AI

Bookmark

Review highlights clinical and molecular features in rare melanoma subtypes, suggesting the urgent need for tailored therapeutic approaches.